近 2 0年来妇科肿瘤联合化疗有了长足的进步。术后顺铂联合化疗改善了晚期卵巢癌病人的生存质量。 2 0世纪 90年代紫杉醇的临床应用 ,不但改善了卵巢癌二线治疗的疗效 ,而且由紫杉醇、顺铂代替顺铂、环磷酰胺联合化疗作为术后一线治疗 ,使晚期病人的中位生存期进一步延长。近年 Gynecologic oncology combined with chemotherapy has made great progress in the past 20 years. Postoperative cisplatin combined with chemotherapy improved the quality of life in patients with advanced ovarian cancer. The clinical application of paclitaxel in the 1990s not only improved the efficacy of second-line treatment of ovarian cancer, but also used paclitaxel and cisplatin in place of cisplatin and cyclophosphamide combined with chemotherapy as the first-line postoperative treatment. The median survival of advanced patients was further improved. extend. in recent years